ATTERX

As a specialty pharmaceutical company, Atterx has received initial funding to develop proprietary therapies for the prevention and treatment of multi-drug resistant bacterial infections. Atterx is following a proven clinical strategy, with key milestone targets in place. We bring an experienced management team to this important work with extensive expertise in all aspects of the pharmaceutical industry... Atterx is developing novel products that prevent and treat antibiotic- resistant bacterial infections. Antibiotics and have saved millions of lives since they were introduced decades ago. Bacteria that were once easy to treat with antibiotics are now changing and becoming resistant to them.

Primary location: Traverse City United States